ArriVent BioPharma Inc (AVBP)
NASDAQ
Year End December 30 2023 | 2022 | 2023 |
---|---|---|
USD ($) | USD ($) | |
Return on Assets (%) | -40.371 | -40.085 |
Return on Equity (%) | 86.726 | 58.189 |
Return on Invested Capital (%) | -42.326 | -46.208 |
Operating Margin (%) | N/A | N/A |
Net Profit Margin (%) | N/A | N/A |
Book Value Per Share | 0.593 | 0.504 |
Earnings Per Share | -0.125 | -0.231 |
Cash Per Share | 0.555 | 0.501 |
Working Capital Per Share | 0.592 | 0.494 |
Operating Profit Per Share | N/A | N/A |
EBIT Per Share | -0.125 | -0.231 |
EBITDA Per Share | -0.125 | -0.231 |
Free Cash Flow Per Share | -0.125 | -0.231 |
Year End December 30 2023 | 2022 | 2023 |
---|---|---|
Current Ratio | N/A | N/A |
Quick Ratio | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A |
Shares Outstanding | 39.51M | 2.75M |
Year End December 30 2023 | Dec 2023 | Mar 2024 |
---|---|---|
USD ($) | USD ($) | |
Shares Outstanding | 2.75M | N/A |
Return on Assets (%) | N/A | N/A |
Return on Equity (%) | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A |
Operating Margin (%) | N/A | N/A |
Net Profit Margin (%) | N/A | N/A |
Sales Per Share | N/A | N/A |
Book Value Per Share | N/A | N/A |
Earnings Per Share | N/A | N/A |
Cash Per Share | N/A | N/A |
Working Capital Per Share | N/A | N/A |
Operating Profit Per Share | N/A | N/A |
EBIT Per Share | N/A | N/A |
EBITDA Per Share | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A |
Current Ratio | N/A | N/A |
Quick Ratio | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A |
Market Cap | 943.09M |
Price to Earnings Ratio | -13.18 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 6.07 |
Price to Book Ratio | 6.04 |
Dividend Yield | - |
Shares Outstanding | 33.59M |
Average Volume (1 week) | 172.73k |
Average Volume (1 Month) | 142.91k |
52 Week Change | 13.38% |
52 Week High | 36.37 |
52 Week Low | 14.35 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.